Trial intelligence / Profile preview

Forteo vs Actonel for Back Pain in Postmenopausal Osteoporosis

NCT00343252Phase 3Completed

Sponsor
Eli Lilly and Company
Start
Jun 2006
Primary completion
Jun 2009
Countries
13
01

Overview

A Phase 3 trial of teriparatide in osteoporosis, back pain, spinal fracture, sponsored by Eli Lilly and Company. Started Jun 2006; status: completed.

02

Drugs

teriparatide
03

Conditions

osteoporosisback painspinal fracture

Beyond the preview

Go deeper on NCT00343252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00343252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call